Search publications

Publications

  • De Bortoli M, Ivars M, Revencu N, Nassogne MC, Lavarino C, Paco-Mercader S, Lammens M, Renders A, Dumitriu D, Helaers R, Boon LM, Baselga E and Vikkula M.

    Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants

    AMERICAN JOURNAL OF MEDICAL GENETICS PART A . : .

    [doi:10.1002/ajmg.a.63551]

  • Pinto EM, Fridman C, Figueiredo BC, Salvador-Hernandez H, Teixeira MR, Pinto C, Pinheiro M, Kratz CP, Lavarino C, Legal EAMF, Le A, Kelly G, Koeppe E, Stoffel EM, Breen K, Hahner S, Heinze B, Techavichit P, Krause A, Ogata T, Fujisawa Y, Walsh MF, Rana HQ, Maxwell KN, Garber JE, Rodriguez-Galindo C, Ribeiro RC and Zambetti GP.

    Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility

    Human Genetics and Genomics Advances . 5(1): 100244-100244.

    [doi:10.1016/j.xhgg.2023.100244]

  • Simao-Rafael M, Cruz-Martínez O, Pérez-Jaume S, Santa-María López V, Lavarino C, Salvador-Hernandez H, Muchart-Lopez J, Hinojosa J, Suñol M and Morales-La Madrid A.

    Use of bevacizumab in pediatric low-grade glioma: Ten-year experience in a single center

    EJC Paediatric Oncology . 2: 100115.

    [doi:10.1016/j.ejcped.2023.100115]

  • Gomez-Gonzalez S, Llano J, Garcia-López M, Garrido- García A, Suñol M, Lemos I, Pérez-Jaume S, Salvador-Marcos N, Gene-Olaciregui N, Galán RA, Santa-María López V, Pérez-Somarriba M, Castañeda-Heredia A, Hinojosa J, Winter U, Moreira FB, Lubieniecki F, Vazquez V, Mora J, Cruz-Martínez O, Morales-La Madrid A, Perera A and Lavarino C.

    EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping

    iScience . 26(9): 107598-107598.

    [doi:10.1016/j.isci.2023.107598]

  • Fanlo, L, Gomez-Gonzalez S, Rozalen, C, Perez-Nunez, I, Sangrador, I, Tomas-Daza, L, Gautier, EL, Usieto, S, Rebollo, E, Vilà-Ubach M, Carcaboso AM, Javierre, BM, Celia-Terrassa, T, Lavarino C, Marti, E and Le Dreau, G.

    Neural crest-related NXPH1/a-NRXN signaling opposes neuroblastoma malignancy by inhibiting organotropic metastasis

    Oncogene . 42(28): 2218-2233.

    [doi:10.1038/s41388-023-02742-2]

  • Esperanza-Cebollada E, Gomez-Gonzalez S, Pérez-Jaume S, Vega-García N, Vicente-Garces C, Richarte M, Rives-Solà S, Català-Temprano A, Torrebadell-Burriel M and Camós-Guijosa M.

    A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia

    BRITISH JOURNAL OF HAEMATOLOGY . 202(1): 96-110. Number of citations: 2

    [doi:10.1111/bjh.18746]

  • Aschero MR, Castillo H, Baulenas-Farrés M, Resa-Parés C, Jiménez-Cabaco A, Rodriguez E, Monterrubio C, Pérez-Jaume S, Suñol M, Chantada G, Lavarino C, Mora J and Carcaboso AM.

    Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma

    PEDIATRIC BLOOD & CANCER . 70(6): . Number of citations: 2

    [doi:10.1002/pbc.30318]

  • Mora J, Castañeda-Heredia A, Gorostegui-Obanos M, Varo A, Pérez-Jaume S, Simao M, Muñoz JP, Garraus-Oneca M, Cristina Larrosa Espinosa, Salvador-Marcos N, Lavarino C, Krauel L and Mañe S.

    Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report

    Cancers . 15(9): . Number of citations: 3

    [doi:10.3390/cancers15092535]

  • Carton, C, Evans, DG, Blanco, I, Friedrich, RE, Ferner, RE, Farschtschi, S, Salvador-Hernandez H, Azizi, AA, Mautner, V, Rohl, C, Peltonen, S, Stivaros, S, Legius, E and Oostenbrink, R.

    ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

    EClinicalMedicine . 56: . Number of citations: 18

    [doi:10.1016/j.eclinm.2022.101818]

  • Pascual-Pastó G, Resa-Parés C, Castillo H, Aschero MR, Baulenas-Farrés M, Vilà-Ubach M, Burgeño-Sandoval V, Balaguer-Lluna L, Cuadrado-Vilanova M, Gene-Olaciregui N, Martinez N, Pérez-Jaume S, de Alava, E, Tirado, OM, Lavarino C, Mora J and Carcaboso AM.

    Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma

    BIOCHEMICAL PHARMACOLOGY . 208: 115408-115408. Number of citations: 4

    [doi:10.1016/j.bcp.2022.115408]